Lavenburg Philip, Cantor Gregg, Agunloye Olufunmilayo, Bhagat Aditi, Taub Erin, Teressa Getu
From the Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY.
Crit Pathw Cardiol. 2019 Mar;18(1):32-39. doi: 10.1097/HPC.0000000000000167.
The aim of this study was to evaluate whether pretest probability (PTP) assessment using the Diamond-Forrester Model (DFM) combined with coronary calcium scoring (CCS) can safely rule out obstructive coronary artery disease (CAD) and 30-day major adverse cardiovascular events (MACE) in acute chest pain patients.
We retrospectively evaluated consecutive patients, age ≥18 years, with no known CAD, negative initial electrocardiogram, and troponin level. All patients had coronary computed tomographic angiography (CCTA) with CCS, and our final cohort consisted of 1988 patients. Obstructive CAD was defined as luminal narrowing of ≥50% in 1 or more vessels by CCTA. Patients were classified according to PTP as low (<10%), intermediate (10%-90%), or high (>90%).
The DFM classified 293 (14.7%), 1445 (72.7%), and 250 (12.6%) of patients as low, intermediate, and high risk, respectively, with corresponding 30-day MACE rates of 0.0%, 2.35%, and 14.8%. For patients with intermediate PTP and CCS ≤10, the negative predictive value was 99.2% (95% confidence interval: 98.7-99.8) for 30-day MACE while it was 92.62% (95% confidence interval: 87.9-97.3) for patients with high PTP. Among patients with a high PTP and CCS of zero, the prevalence of 30-day MACE and obstructive CAD remained high (7.07% and 10.1%, respectively).
In acute chest pain patients without evidence of ischemia on initial electrocardiogram and cardiac troponin, low PTP by DFM or the combination of intermediate PTP and CCS ≤10 had excellent negative predictive values to rule out 30-day MACE. CCS is not sufficient to exclude obstructive CAD and 30-day MACE in patients with high PTP.
本研究的目的是评估使用钻石-福雷斯特模型(DFM)结合冠状动脉钙化评分(CCS)进行的预测试概率(PTP)评估能否安全地排除急性胸痛患者的阻塞性冠状动脉疾病(CAD)和30天主要不良心血管事件(MACE)。
我们回顾性评估了年龄≥18岁、无已知CAD、初始心电图和肌钙蛋白水平为阴性的连续患者。所有患者均接受了带有CCS的冠状动脉计算机断层血管造影(CCTA),我们的最终队列包括1988名患者。阻塞性CAD定义为CCTA显示1条或多条血管管腔狭窄≥50%。患者根据PTP分为低(<10%)、中(10%-90%)或高(>90%)风险组。
DFM将293例(14.7%)、1445例(72.7%)和250例(12.6%)患者分别分类为低、中、高风险,相应的30天MACE发生率分别为0.0%、2.35%和14.8%。对于中PTP且CCS≤10的患者,30天MACE的阴性预测值为99.2%(95%置信区间:98.7-99.8),而高PTP患者的阴性预测值为92.62%(95%置信区间:87.9-97.3)。在高PTP且CCS为零的患者中,30天MACE和阻塞性CAD的患病率仍然很高(分别为7.07%和10.1%)。
在初始心电图和心肌肌钙蛋白无缺血证据的急性胸痛患者中,DFM的低PTP或中PTP与CCS≤10的组合具有出色的阴性预测值,可排除30天MACE。CCS不足以排除高PTP患者的阻塞性CAD和30天MACE。